Icon

VERQUVO (nda214377)- (2.5MG,5MG,10MG)

VERICIGUAT MSD
2.5MG,5MG,10MG
No No
2032-Nov-26 2026-Jan-19
None None
None No
VERQUVO is a soluble guanylate cyclase (sGC) stimulator, indicated to reduce the risk of cardiovascular death and heart failure (HF) hospitalization following a hospitalization for heart failure or need for outpatient IV diuretics, in adults with symptomatic chronic HF and ejection fraction less than 45%.
0 0 0
Total Other Developers 7
Drugs with Suitability No
2.5MG ** ** - - -
5MG ** ** Up - -
10MG ** ** Up - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.